The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling
Open accessAbstract
The MAPKs are important transducers of growth and stress stimuli in virtually all eukaryotic cell types. In the mammalian heart, MAPK signaling pathways have been hypothesized to regulate myocyte growth in response to developmental signals or physiologic and pathologic stimuli. Here we generated cardiac-specific transgenic mice expressing dominant-negative mutants of p38alpha, MKK3, or MKK6. Remarkably, attenuation of cardiac p38 activity produced a progressive growth response and myopathy in the heart that correlated with the degree of enzymatic inhibition. Moreover, dominant-negative p38alpha, MKK3, and MKK6 transgenic mice each showed enhanced cardiac hypertrophy following aortic banding, Ang II infusion, isoproterenol infusion, or phenylephrine infusion for 14 days. A mechanism underlying this enhanced-growth profile was suggested by the observation that dominant-negative p38alpha directly augmented nuclear factor of activated T cells (NFAT) transcriptional activity and its nuclear translocation. In vivo, NFAT-dependent luciferase reporter transgenic mice showed enhanced activation in the presence of the dominant-negative p38alpha transgene before and after the onset of cardiac hypertrophy. More significantly, genetic disruption of the calcineurin Abeta gene rescued hypertrophic cardiomyopathy and depressed functional capacity observed in p38-inhibited mice. Collectively, these observations indicate that reduced p38 signaling in the heart promotes myocyte growth through a mechanism involving enhanced calcineurin-NFAT signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citationThe epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,247
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
Organization and regulation of mitogen-activated protein kinase signaling pathways
Garrington, T. P., & Johnson, G. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80028-3 · Cited by 1,275
Left Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Wang, Y., Huang, S., Sah, V. P., Ross, J., Brown, J. H., Han, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2161 · Cited by 842
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
Self-citationEnslen, H., Raingeaud, J., & Davis, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1741 · Cited by 539
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., & Nebreda, A. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00014-6 · Cited by 516
Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 513
Kumar, S., McDonnell, P. C., Gum, R. J., Hand, A. T., Lee, J. C., & Young, P. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6849 · Cited by 506
Jiang, Y., Gram, H., Zhao, M., New, L., Gu, J., Feng, L., Di Padova, F., Ulevitch, R. J., & Han, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30122 · Cited by 489
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Essential role for p38α mitogen-activated protein kinase in placental angiogenesis
Mudgett, J. S., Ding, J., Guh-Siesel, L., Chartrain, N. A., Yang, L., Gopal, S., & Shen, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316397 · Cited by 372
Zhang, D., Gaussin, V., Taffet, G. E., Belaguli, N. S., Yamada, M., Schwartz, R. J., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (2000) · Nature Medicine · doi:10.1038/75037 · Cited by 337
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P., Georgakopoulos, D., Kovacs, A., Zheng, M., Lerner, D., Pu, H., Saffitz, J., Chien, K., Xiao, R.-P., Kass, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211086598 · Cited by 333
Purcell, N. H., Tang, G., Yu, C., Mercurio, F., DiDonato, J. A., & Lin, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111155798 · Cited by 323
Zechner, D., Thuerauf, D. J., Hanford, D. S., McDonough, P. M., & Glembotski, C. C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.115 · Cited by 313
Clerk, A., Michael, A., & Sugden, P. H. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.523 · Cited by 308
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Self-citationTransgenic expression of green fluorescence protein can cause dilated cardiomyopathy
Huang, W.-Y., Aramburu, J., Douglas, P. S., & Izumo, S. (2000) · Nature Medicine · doi:10.1038/74914 · Cited by 271
Wilkins, B. J., De Windt, L. J., Bueno, O. F., Braz, J. C., Glascock, B. J., Kimball, T. F., & Molkentin, J. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7603-7613.2002 · Cited by 262
Self-citationImpaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072647999 · Cited by 237
Self-citationNemoto, S., Sheng, Z., & Lin, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3518 · Cited by 230
Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart
De Windt, L. J., Lim, H. W., Haq, S., Force, T., & Molkentin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13571 · Cited by 226
Self-citationMechanical strain activates BNP gene transcription through a p38/NF-κB–dependent mechanism
Liang, F., & Gardner, D. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7362 · Cited by 213
Jones, W. K., Grupp, I. L., Doetschman, T., Grupp, G., Osinska, H., Hewett, T. E., Boivin, G., Gulick, J., Ng, W. A., & Robbins, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118992 · Cited by 200
Self-citationRole of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
Choukroun, G., Hajjar, R., Kyriakis, J. M., Bonventre, J. V., Rosenzweig, A., & Force, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3512 · Cited by 193
Defective T cell development and function in calcineurin Aβ-deficient mice
Bueno, O. F., Brandt, E. B., Rothenberg, M. E., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152665399 · Cited by 188
Self-citationLiu, Y., Cseresnyés, Z., Randall, W. R., & Schneider, M. F. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103020 · Cited by 182
Phosphorylation of NFATc4 by p38 Mitogen-Activated Protein Kinases
Yang, T. T. C., Xiong, Q., Enslen, H., Davis, R. J., & Chow, C.-W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3892-3904.2002 · Cited by 174
Porter, C. M., Havens, M. A., & Clipstone, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3543 · Cited by 167
A Role for the p38 MAP Kinase Pathway in the Nuclear Shuttling of NFATp
del Arco, P. G., Martı́nez-Martı́nez, S., Maldonado, J. L., Ortega-Pérez, I., & Redondo, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13872 · Cited by 159
Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy
Lim, H. W., De Windt, L. J., Steinberg, L., Taigen, T., Witt, S. A., Kimball, T. R., & Molkentin, J. D. (2000) · Circulation · doi:10.1161/01.cir.101.20.2431 · Cited by 158
Self-citationHunton, D. L., Lucchesi, P. A., Pang, Y., Cheng, X., Dell’Italia, L. J., & Marchase, R. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107167200 · Cited by 156
Zanke, B. W., Rubie, E. A., Winnett, E., Chan, J. C.-Y., Randall, S., Parsons, M., Boudreau, K., McInnis, M., Yan, M., Templeton, D. J., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29876 · Cited by 102
Transgenic Remodeling of the Regulatory Myosin Light Chains in the Mammalian Heart
Gulick, J. M., Hewett, T. E., Klevitsky, R., Buck, S. H., Moss, R. L., & Robbins, J. M. (1997) · Circulation Research · doi:10.1161/01.res.80.5.655 · Cited by 88
Self-citationNg, D. C. H., Long, C. S., & Bogoyevitch, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100699200 · Cited by 69
Court, N. W., dos Remedios, C. G., Cordell, J., & Bogoyevitch, M. A. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1523 · Cited by 59
Essential Role of p38? MAP Kinase in Placental but Not Embryonic Cardiovascular Development
ADAMS, R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00012-5 · Cited by 55
van Zwieten, P. A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00291-6 · Cited by 44
Cited by
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Self-citationp38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Rose, B. A., Force, T., & Wang, Y. (2010) · Physiological Reviews · doi:10.1152/physrev.00054.2009 · Cited by 723
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Kehat, I., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.110.942268 · Cited by 592
Self-citation
Metadata
- Authors
- Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., Hewett, T. E., & Molkentin, J. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-05-15
- Volume
- 111
- Issue
- 10
- Pages
- 1475-1486
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2134686559
- Cited by
- 332
- References
- 43
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.